Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiac Catheterization III: Left Heart Catheterization

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiac Catheterization II: Right Heart Catheterization

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...

Chambers of the Heart

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimized extraction of Pinus taeda knotwood sawmill residues as source of antifungal compounds.

Bioresources and bioprocessing·2026

Same author

Wire puncture technique for placement of perfusion sheath during venous-arterial extracorporeal membrane oxygenation.

The journal of vascular access·2026

Same author

Phenol-Formaldehyde Adhesives Modified with Eucalyptus Lignin: The Advantages of Soda Lignin.

Polymers·2025

Same author

A new hybrid echocardiography and arterial pressure waveform approach for non-invasive reconstruction of the entire left ventricular pressure waveform.

European heart journal. Imaging methods and practice·2025

Same author

Assessment of Myocardial Injury Size Metrics Using Carotid Pressure Waveform: Proof-of-Concept in Coronary Occlusion/Reperfusion Rat Model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025

Same author

Periprocedural Results and Right Ventricular Outcomes of Computer Assisted Vacuum Thrombectomy Treatment of Acute Pulmonary Embolism: Interim Analysis of 300 Patients From the STRIKE-PE Study.

Journal of the American Heart Association·2025

Search research articles

Related Experiment Video

Updated: May 28, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Percutaneous devices to support the left ventricle.

David M Shavelle¹, Leonardo Clavijo, Ray V Matthews

¹Division of Cardiovascular Medicine, University of Southern California, Los Angeles, CA, USA. shavelle@usc.edu

Expert Review of Medical Devices

|October 28, 2011

Summary

This review covers percutaneous left ventricular assist devices (pLVADs) for high-risk procedures and cardiogenic shock. It details device function, implantation, hemodynamic effects, and clinical trial outcomes.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Cardiology
Medical Devices
Interventional Cardiology

Background:

Percutaneous left ventricular assist devices (pLVADs) are emerging as crucial tools in managing complex cardiovascular conditions.
High-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock (CS) represent critical scenarios where mechanical circulatory support is often necessary.

Purpose of the Study:

To provide a comprehensive overview of the current landscape of three key percutaneous left ventricular assist devices.
To elucidate the technical aspects, including device composition and implantation procedures for pLVADs.
To analyze the hemodynamic alterations associated with pLVAD implantation and summarize clinical evidence.

Main Methods:

Literature review of published clinical trials and ongoing studies on selected pLVADs.
Analysis of technical specifications and device components.
Review of hemodynamic data from clinical studies and case reports.

Main Results:

Summary of the current status and technical features of three prominent pLVADs.
Discussion of expected and observed hemodynamic changes post-implantation.
Overview of clinical trial results for pLVADs in HR-PCI and CS populations.

Conclusions:

Percutaneous left ventricular assist devices offer a minimally invasive option for hemodynamic support in high-risk cardiac patients.
Further clinical trials are essential to define the optimal use and long-term outcomes of these devices.
pLVADs show promise in improving outcomes for patients undergoing HR-PCI and those in cardiogenic shock.